News

An off-the-shelf cancer vaccine that targets KRAS mutations induced T-cell responses and was associated with impressive ...
Scripps News speaks with vaccine experts who say HHS funding cuts targeting mRNA vaccines could hinder other vaccine research ...
The mKRAS-targeting cancer vaccine reduced the risk of death by 77% by activating the anti-tumour mechanisms of key immune ...
Dr. Zev Wainberg of UCLA recently spoke with CURE about trial results concerning the cancer vaccine ELI-002 2P.
A new pancreatic cancer vaccine has appeared to slow disease progression and increase survival for patients in an early trial ...
The Trump administration’s COVID-revenge campaign has laid the groundwork for Kennedy’s larger agenda.
A novel vaccine designed to target one of the most common cancer-driving mutations in patients with pancreatic and colorectal ...
Oregon Health & Science University said a trained AI program can detect cancer of a larynx by picking up the distinct ...
Federal funding cuts to mRNA technology research doesn't just impact COVID vaccines — experts say it could stall progress in ...
Federal funding cuts to mRNA technology research doesn't just impact COVID vaccines — experts say it could stall progress in treatment for cancers, rare disease and more.
A new vaccine for pancreatic cancer has shown potential in early trials, slowing disease progression and increasing survival rates. The vaccine was tested in a phase 1 trial involving 20 pancreatic ...
It ain’t what you don’t know that gets you into trouble. It’s what you know for sure that just ain’t so.” Mark Twain’s quip ...